The TRANSEVER registry - A prospective, open-label, multicentre, post market surveillance study of ISAR SUMMIT polymer-free Everolimus eluting stent in a real-world Indian population of patients with coronary artery disease: One-year outcomes of the first 500 enrolled patients.

Praveen Chandra, Yash Paul Sharma, Rajneesh Kapoor, Rahul Singhal, Pushpraj Patel, Anupam Jena, Dileep Kumar Tiwari, Rohit Mody, Amjad Ali, Sudeep Kumar, Jola Bresha, Adnan Kastrati